New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs

Smith, 2015, Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network, Br J Cancer, 112, 1575, 10.1038/bjc.2015.94

Tan, 2013, Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience, Blood, 122, 981, 10.1182/blood-2013-03-491514

Tsujimoto, 1985, Involvement of the bcl-2 gene in human follicular lymphoma, Science, 228, 1440, 10.1126/science.3874430

McDonnell, 1991, Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18), Nature, 349, 254, 10.1038/349254a0

Pastore, 2015, Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry, Lancet Oncol, 16, 1111, 10.1016/S1470-2045(15)00169-2

Jurinovic, 2016, Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy, Blood, 128, 1112, 10.1182/blood-2016-05-717355

Aster, 2002, Detection of BCL2 rearrangements in follicular lymphoma, Am J Pathol, 160, 759, 10.1016/S0002-9440(10)64897-3

Tsujimoto, 1985, The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining, Science, 229, 1390, 10.1126/science.3929382

Llambi, 2011, A unified model of mammalian BCL-2 protein family interactions at the mitochondria, Mol Cell, 44, 517, 10.1016/j.molcel.2011.10.001

Rong, 2009, The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor, Proc Natl Acad Sci, 106, 14397, 10.1073/pnas.0907555106

Borner, 1996, Diminished cell proliferation associated with the death-protective activity of Bcl-2, J Biol Chem, 271, 12695, 10.1074/jbc.271.22.12695

Lavik, 2015, A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2, Oncotarget, 6, 27388, 10.18632/oncotarget.4489

Sungalee, 2014, Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression, J Clin Invest, 124, 5337, 10.1172/JCI72415

Roulland, 2011, Early steps of follicular lymphoma pathogenesis, Adv Immunol, 111, 1, 10.1016/B978-0-12-385991-4.00001-5

Kridel, 2016, Histological transformation and progression in follicular lymphoma: a clonal evolution study, PLoS Med, 13, 10.1371/journal.pmed.1002197

Mamessier, 2014, Nature and importance of follicular lymphoma precursors, Haematologica, 99, 802, 10.3324/haematol.2013.085548

Okosun, 2014, Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma, Nat Genet, 46, 176, 10.1038/ng.2856

Bouska, 2017, Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma, Leukemia, 31, 83, 10.1038/leu.2016.175

Pasqualucci, 2014, Genetics of follicular lymphoma transformation, Cell Rep, 6, 130, 10.1016/j.celrep.2013.12.027

Green, 2015, Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation, Proc Natl Acad Sci, 112, E1116, 10.1073/pnas.1501199112

Guo, 2012, Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways, Proc Natl Acad Sci, 109, 17603, 10.1073/pnas.1208807109

Kantidakis, 2016, Mutation of cancer driver MLL2 results in transcription stress and genome instability, Genes Dev, 30, 408, 10.1101/gad.275453.115

Zhang, 2015, Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis, Nat Med, 21, 1190, 10.1038/nm.3940

Maniati, 2013, Investigating the role of MLL2 (Mll4) in B cell development, Blood, 122

Ortega-Molina, 2015, The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development, Nat Med, 21, 1199, 10.1038/nm.3943

Bödör, 2013, EZH2 mutations are frequent and represent an early event in follicular lymphoma, Blood, 122, 3165, 10.1182/blood-2013-04-496893

Béguelin, 2013, EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation, Cancer Cell, 23, 677, 10.1016/j.ccr.2013.04.011

Berg, 2014, A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis, Blood, 123, 3914, 10.1182/blood-2012-12-473439

Giatromanolaki, 2008, Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation, Hematol Oncol, 26, 219, 10.1002/hon.861

McCabe, 2012, EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations, Nature, 492, 108, 10.1038/nature11606

Morera, 2016, Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy, Clin Epigenetics, 8, 57, 10.1186/s13148-016-0223-4

Huet, 2017, EZH2 alterations in follicular lymphoma: biological and clinical correlations, Blood Cancer J, 7, e555, 10.1038/bcj.2017.32

Pasini, 2010, Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes, Nucleic Acids Res, 38, 4958, 10.1093/nar/gkq244

Pasqualucci, 2011, Inactivating mutations of acetyltransferase genes in B-cell lymphoma, Nature, 471, 189, 10.1038/nature09730

Jiang, 2016, CREBBP inactivation promotes the development of HDAC3 dependent lymphomas, Cancer Discov

Kridel, 2015, Cell of origin of transformed follicular lymphoma, Blood, 126, 2118, 10.1182/blood-2015-06-649905

Bereshchenko, 2002, Acetylation inactivates the transcriptional repressor BCL6, Nat Genet, 32, 606, 10.1038/ng1018

Grossman, 2001, p300/CBP/p53 interaction and regulation of the p53 response, Eur J Biochem, 268, 2773, 10.1046/j.1432-1327.2001.02226.x

Bouska, 2014, Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma, Blood, 123, 1681, 10.1182/blood-2013-05-500595

Li, 2014, Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma, Blood, 123, 1487, 10.1182/blood-2013-05-500264

Chen, 2015, A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma, Haematologica, 100, 357, 10.3324/haematol.2014.117473

Linley, 2015, Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells, Blood, 126, 1902, 10.1182/blood-2015-04-640805

Amin, 2015, DC-SIGN–expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma, Blood, 126, 1911, 10.1182/blood-2015-04-640912

Irish, 2006, Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells, Blood, 108, 3135, 10.1182/blood-2006-02-003921

Sachen, 2012, Self-antigen recognition by follicular lymphoma B-cell receptors, Blood, 120, 4182, 10.1182/blood-2012-05-427534

Seda, 2015, B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells, Eur J Haematol, 94, 193, 10.1111/ejh.12427

Fruman, 2004, Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling, Curr Opin Immunol, 16, 314, 10.1016/j.coi.2004.03.014

Musilova, 2015, MicroRNAs in B-cell lymphomas: how a complex biology gets more complex, Leukemia, 29, 1004, 10.1038/leu.2014.351

Musilova, 2018, miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels, Blood, 10.1182/blood-2018-06-855502

Mraz, 2014, miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1, Blood, 124, 84, 10.1182/blood-2013-09-527234

Miletic, 2010, Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases, J Exp Med, 207, 2407, 10.1084/jem.20091962

Victora, 2010, Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter, Cell, 143, 592, 10.1016/j.cell.2010.10.032

Gitlin, 2014, Clonal selection in the germinal center by regulated proliferation and hypermutation, Nature, 509, 637, 10.1038/nature13300

Shulman, 2014, Dynamic signaling by T follicular helper cells during germinal center B cell selection, Science, 345, 1058, 10.1126/science.1257861

Khalil, 2012, B cell signal transduction in germinal center B cells is short-circuited by increased phosphatase activity, Science, 336, 1178, 10.1126/science.1213368

Nowosad, 2016, Germinal center B cells recognize antigen through a specialized immune synapse architecture, Nat Immunol, 17, 870, 10.1038/ni.3458

Amé-Thomas, 2012, Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells, Leukemia, 26, 1053, 10.1038/leu.2011.301

Wang, 2012, MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response, Haematologica, 97, 586, 10.3324/haematol.2011.048132

Oricchio, 2011, The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma, Cell, 147, 554, 10.1016/j.cell.2011.09.035

Karube, 2014, Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours, J Pathol, 234, 423, 10.1002/path.4428

Hildebrand, 2010, A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling, J Exp Med, 207, 2569, 10.1084/jem.20100857

Fowler, 2016, Ibrutinib combined with rituximab in treatment-naive patients with follicular lymphoma: arm 1 + arm 2 results from a multicenter, open-label phase 2 study, Blood, 128, 10.1182/blood.V128.22.1804.1804

Salles, 2017, Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study, Haematologica, 102, e156, 10.3324/haematol.2016.151738

Witzig, 2011, A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma, Leukemia, 25, 341, 10.1038/leu.2010.226

Advani, 2015, Two doses of polatuzumab vedotin (PoV, anti-CD79b antibody-drug conjugate) in patients (pts) with relapsed/refractory (RR) follicular lymphoma (FL): durable responses at lower dose level, J Clin Oncol, 33, 10.1200/jco.2015.33.15_suppl.8503

Cheng, 2015, MicroRNA silencing for cancer therapy targeted to the tumour microenvironment, Nature, 518, 107, 10.1038/nature13905

De Silva, 2015, Dynamics of B cells in germinal centres, Nat Rev Immunol, 15, 137, 10.1038/nri3804

Akasaka, 2003, BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma, Blood, 102, 1443, 10.1182/blood-2002-08-2482

Ying, 2013, MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma, Nat Immunol, 14, 1084, 10.1038/ni.2688

Morin, 2011, Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma, Nature, 476, 298, 10.1038/nature10351

Pasqualucci, 2003, Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma, Blood, 101, 2914, 10.1182/blood-2002-11-3387

Dominguez-Sola, 2015, The FOXO1 transcription factor instructs the germinal center dark zone program, Immunity, 43, 1064, 10.1016/j.immuni.2015.10.015

Trinh, 2013, Analysis of FOXO1 mutations in diffuse large B-cell lymphoma, Blood, 121, 3666, 10.1182/blood-2013-01-479865

Inoue, 2017, The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help, J Exp Med, 214, 1181, 10.1084/jem.20161263

Phan, 2004, The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells, Nature, 432, 635, 10.1038/nature03147

Chim, 2007, Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma, Hum Pathol, 38, 1849, 10.1016/j.humpath.2007.05.009

Klein, 2003, Transcriptional analysis of the B cell germinal center reaction, Proc Natl Acad Sci, 100, 2639, 10.1073/pnas.0437996100

Pérez-Roger, 1997, Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes, Oncogene, 14, 2373, 10.1038/sj.onc.1201197

Mihailovich, 2015, miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth, Nat Commun, 6, 8725, 10.1038/ncomms9725

O'Donnell, 2005, c-Myc-regulated microRNAs modulate E2F1 expression, Nature, 435, 839, 10.1038/nature03677

Cerna, 2018, MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells, Leukemia, 10.1038/s41375-018-0230-x

Edlefsen, 2014, Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype, Int J Cancer, 135, 913, 10.1002/ijc.28724

Westin, 2014, Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial, Lancet Oncol, 15, 69, 10.1016/S1470-2045(13)70551-5

Rawal, 2013, Cross talk between follicular helper T cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment, J Immunol Baltim Md 1950, 190, 6681

Ai, 2009, Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T regulatory cells, Int J Cancer J Int Cancer, 124, 239, 10.1002/ijc.23881

Nedelkovska, 2016, Follicular lymphoma tregs have a distinct transcription profile impacting their migration and retention in the malignant lymph node, PloS One, 11, 10.1371/journal.pone.0155347

Farinha, 2010, The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation, Blood, 115, 289, 10.1182/blood-2009-07-235598

Xiu, 2015, IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma, Blood Cancer J, 5, e328, 10.1038/bcj.2015.56

Li, 2002, Follicular dendritic cell-signaling molecules required for proliferation and differentiation of GC-B cells, Semin Immunol, 14, 259, 10.1016/S1044-5323(02)00058-1

Mraz, 2011, Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance, Br J Haematol, 155, 53, 10.1111/j.1365-2141.2011.08794.x

Lwin, 2010, Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a, Blood, 116, 5228, 10.1182/blood-2010-03-275925

Pavlasova, 2018, Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels, Leukemia, 32, 2028, 10.1038/s41375-018-0211-0

Pavlasova, 2016, Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis, Blood, 128, 1609, 10.1182/blood-2016-04-709519

Okosun, 2016, Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma, Nat Genet, 48, 183, 10.1038/ng.3473